Intravitreal Devices for the Treatment of Vitreous Inflammation

Table 4

Comparison of intravitreal implants for the treatment of noninfectious uveitis [40].

	0.59 mg fluocinolone acetonide (FA) implant	0.7 mg dexamethasone (DEX) implant
Administration	Operating room	Officebased
Matrix	Non-biodegradable	Biodegradable
Duration of effect	30 months	6 months
Improvement of >15 letters (% eyes)	21% by week 34	38% by week 26
Rescue medications (% eyes)	25.4% by week 34	22% by week 26
Glaucoma surgery (% eyes)	30.6% by month 24	0.5% by month 6
Cataract surgery (% eyes)	89.4% by month 24	4% by month 6